ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Research Article

Open Vet J. 2025; 15(8): 3848-3853


Therapeutic potential of L-Carnitine in improving adenine-induced hematological abnormalities in rats: A preclinical pharmacological study

Waleed Khaled Y. Albahadly, Mohammed Jasim Jawad, Mohammed Ibrahim Rasool, Haider Falih ShamikhAl-Saedi, Asia Ali Hamza.



Abstract
Download PDF Cited by 0 ArticlesPost

Background:
Adenine is a naturally occurring purine essential for life, but its excess intake can cause metabolic disturbances leading to cardiovascular complications, renal stones, gout, fatigue, and anemia.

Aim:
This study aimed to investigate the potential hematological protective effects of L-Carnitine in rats subjected to adenine-induced toxicity.

Methods:
Twenty-four adult male Wistar rats were randomly assigned to four groups (n = 6). Group 1 received 3 ml of normal saline orally. Group 2 received 100 mg/kg of adenine orally. Group 3 received oral administration of both adenine (100 mg/kg) and L-Carnitine (750 mg/kg). Group 4 received oral L-Carnitine (750 mg/kg) for 30 days. The hematological parameters were assessed using an automated hematology analyzer.

Results:
Rats treated with adenine alone showed a significant reduction in red blood cells, hemoglobin, packed cell volume, and platelet counts and a marked increase in white blood cell levels (p < 0.05). Co-administration of L-Carnitine significantly ameliorated these hematological alterations.

Conclusion:
L-Carnitine exhibited a hematoprotective effect against adenine-induced toxicity, highlighting its potential therapeutic role in managing metabolic disturbances associated with purine overload.

Key words: L-Carnitine, Hematology, Adenine







Bibliomed Article Statistics

16
96
23
23
24
24
1
R
E
A
D
S

2

44

15

13

23

20


D
O
W
N
L
O
A
D
S
08091011120102
20252026

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.